soul trial oral semaglutide cardiovascular outcomes nejm 2025 results 🧿 is the first oral GLP-1 RA proven to reduce MACE in high-risk T2DM patients, extending protection beyond injectable formulations. Trial: Oral Semaglutide & Cardiovascular in T2DM Oral Semaglutide and Cardiovascular Outcomes

Taken together, these pharmacokinetic findings indicate that the centrally mediated effects of GLP-1RAs are likely due to limited brain penetration or action at sites adjacent to the BBB, rather than widespread distribution throughout the central nervous system

The advertisements and initial consultations with doctors often focus on the benefits weight loss and better blood sugar control but fail to emphasize the severe side effects that can emerge after discontinuation

Research suggests that regularly getting quality sleep may also help regulate hunger and fullness hormones

In his down time to give his brain a rest, he loves to play with kids

BuildLeaf addresses these issues with a potent blend of Lactobacillus rhamnosus , apple cider vinegar , and green tea extract , which: Optimize gut microbiota Reduces bloating and constipation Support detoxification and nutrient absorption Promote fat loss in the abdominal area Safe, gentle, and side-effect-free, this formula restores digestive health for long-term weight control and improved wellness